Idarubicin Injection 20 mg/20 mL (3)

Land: Australië

Taal: Engels

Bron: Department of Health (Therapeutic Goods Administration)

Werkstoffen:

idarubicin hydrochloride, Quantity: 1 mg/mL

Beschikbaar vanaf:

Pfizer (Perth) Pty Ltd

farmaceutische vorm:

Injection, solution

Samenstelling:

Excipient Ingredients: glycerol; hydrochloric acid; water for injections

Toedieningsweg:

Intravenous

Eenheden in pakket:

1 x 20 mL

Prescription-type:

(S1) This Schedule is intentionally blank

therapeutische indicaties:

UK: Zavedos is used in adults and children for the treatment of acute non lymphoblastic leukaemia (ANLL), also referred to as acute myeloid leukaemia (AML). Zavedos is also used in adults and children as a second line treatment of relapsed acute lymphoblastic leukaemia (ALL)

Product samenvatting:

Visual Identification: Red - orange, clear, mobile solution; Container Type: Vial; Container Material: PP; Container Life Time: 36 Months; Container Temperature: Store at 2 to 8 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert

Autorisatie-status:

Listed (Export Only)

Autorisatie datum:

2023-02-17